These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27261333)

  • 1. Delivery of LLKKK18 loaded into self-assembling hyaluronic acid nanogel for tuberculosis treatment.
    Silva JP; Gonçalves C; Costa C; Sousa J; Silva-Gomes R; Castro AG; Pedrosa J; Appelberg R; Gama FM
    J Control Release; 2016 Aug; 235():112-124. PubMed ID: 27261333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small Molecule Mediated Restoration of Mitochondrial Function Augments Anti-Mycobacterial Activity of Human Macrophages Subjected to Cholesterol Induced Asymptomatic Dyslipidemia.
    Asalla S; Mohareer K; Banerjee S
    Front Cell Infect Microbiol; 2017; 7():439. PubMed ID: 29067283
    [No Abstract]   [Full Text] [Related]  

  • 3. Interaction between antimicrobial peptides and mycobacteria.
    Gutsmann T
    Biochim Biophys Acta; 2016 May; 1858(5):1034-43. PubMed ID: 26851776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial peptides as novel anti-tuberculosis therapeutics.
    Silva JP; Appelberg R; Gama FM
    Biotechnol Adv; 2016; 34(5):924-940. PubMed ID: 27235189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetyl-cysteine exhibits potent anti-mycobacterial activity in addition to its known anti-oxidative functions.
    Amaral EP; Conceição EL; Costa DL; Rocha MS; Marinho JM; Cordeiro-Santos M; D'Império-Lima MR; Barbosa T; Sher A; Andrade BB
    BMC Microbiol; 2016 Oct; 16(1):251. PubMed ID: 27793104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of 12 antimicrobial peptides against Mycobacterium tuberculosis and Mycobacterium avium clinical isolates.
    Portell-Buj E; Vergara A; Alejo I; López-Gavín A; Monté MR; San Nicolás L; González-Martín J; Tudó G
    J Med Microbiol; 2019 Feb; 68(2):211-215. PubMed ID: 30570475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Tumor Necrosis Factor Alpha and Interleukin 6 Auto-paracrine Signaling Loop Controls Mycobacterium avium Infection via Induction of IRF1/IRG1 in Human Primary Macrophages.
    Gidon A; Louet C; Røst LM; Bruheim P; Flo TH
    mBio; 2021 Oct; 12(5):e0212121. PubMed ID: 34607464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage Targeted Cellular Carriers for Effective Delivery of Anti-Tubercular Drugs.
    Agnihotri J; Singh S; Wais M; Pathak A
    Recent Pat Antiinfect Drug Discov; 2017; 12(2):162-183. PubMed ID: 29219058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.
    Yang Y; Liu Z; He X; Yang J; Wu J; Yang H; Li M; Qian Q; Lai R; Xu W; Wei L
    J Biol Chem; 2019 May; 294(19):7615-7631. PubMed ID: 30894414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel derivative of the fungal antimicrobial peptide plectasin is active against Mycobacterium tuberculosis.
    Tenland E; Krishnan N; Rönnholm A; Kalsum S; Puthia M; Mörgelin M; Davoudi M; Otrocka M; Alaridah N; Glegola-Madejska I; Sturegård E; Schmidtchen A; Lerm M; Robertson BD; Godaly G
    Tuberculosis (Edinb); 2018 Dec; 113():231-238. PubMed ID: 30514507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo.
    Koga T; Fukuoka T; Doi N; Harasaki T; Inoue H; Hotoda H; Kakuta M; Muramatsu Y; Yamamura N; Hoshi M; Hirota T
    J Antimicrob Chemother; 2004 Oct; 54(4):755-60. PubMed ID: 15347635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of LL-37, CRAMP and antimicrobial peptide-derived compounds E2, E6 and CP26 against Mycobacterium tuberculosis.
    Rivas-Santiago B; Rivas Santiago CE; Castañeda-Delgado JE; León-Contreras JC; Hancock RE; Hernandez-Pando R
    Int J Antimicrob Agents; 2013 Feb; 41(2):143-8. PubMed ID: 23141114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhalable poly(lactic-co-glycolic acid) (PLGA) microparticles encapsulating all-trans-Retinoic acid (ATRA) as a host-directed, adjunctive treatment for Mycobacterium tuberculosis infection.
    O'Connor G; Krishnan N; Fagan-Murphy A; Cassidy J; O'Leary S; Robertson BD; Keane J; O'Sullivan MP; Cryan SA
    Eur J Pharm Biopharm; 2019 Jan; 134():153-165. PubMed ID: 30385419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitogen-activated protein kinases p38 and ERK1/2 regulated control of Mycobacterium avium replication in primary murine macrophages is independent of tumor necrosis factor-α and interleukin-10.
    Klug K; Ehlers S; Uhlig S; Reiling N
    Innate Immun; 2011 Oct; 17(5):470-85. PubMed ID: 20682586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted macrophages delivery of rifampicin-loaded lipid nanoparticles to improve tuberculosis treatment.
    Vieira AC; Magalhães J; Rocha S; Cardoso MS; Santos SG; Borges M; Pinheiro M; Reis S
    Nanomedicine (Lond); 2017 Dec; 12(24):2721-2736. PubMed ID: 29119867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium, and rifampin against M. tuberculosis in cultured human macrophages.
    Crowle AJ; Elkins N; May MH
    Am Rev Respir Dis; 1988 May; 137(5):1141-6. PubMed ID: 3143278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial peptides and proteins in mycobacterial therapy: current status and future prospects.
    Padhi A; Sengupta M; Sengupta S; Roehm KH; Sonawane A
    Tuberculosis (Edinb); 2014 Jul; 94(4):363-73. PubMed ID: 24813349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial peptides for the treatment of pulmonary tuberculosis, allies or foes?
    Rivas-Santiago B; Torres-Juarez F
    Curr Pharm Des; 2018; 24(10):1138-1147. PubMed ID: 29589538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.